Zomedica (ZOMDF · OTC)
The Pet Tech Play
A veterinary diagnostics and therapeutics platform scaling recurring revenue with a clear path to profitability
Bull case for Zomedica
A Multi-Product Vet Ecosystem
Integrated diagnostics and therapeutics deepen customer relationships and increase lifetime value.
Recurring Revenue Engine
Consumables growth compounds as installed base expands, driving predictable, higher-margin revenue.
Clear Path to Breakeven
Visible breakeven milestone provides clear route to profitability and re-rating.
Bear case for Zomedica
Slow Adoption Cycle
Veterinary adoption cycles can delay utilisation and revenue scaling.
Execution Risk
Scaling multiple products requires consistent commercial execution across markets.
Competitive Pressure
Larger incumbents may respond with pricing or bundled offerings.
